Always the masters of droll understatement, the United Kingdom’s Medicines and Healthcare products Regulatory Agency (MHRA) issued a directive today (March 12) noting it was “aware that there are challenges […]
As the drug development process becomes increasingly complex and global in reach, demands on the workforce will continue to escalate and certifications could be a key ingredient to help clinical […]
The rising scourge of the unpredictable coronavirus has made remote trials and remote monitoring more attractive concepts to many in recent weeks. “We’ve seen a lot of interest in telemedicine” […]
Sponsors should make every effort to enroll older adults in their pivotal randomized trials, the U.S. Food and Drug Administration (FDA) says in a new draft guidance. “To encourage and […]
Clinical Researcher—March 2020 (Volume 34, Issue 3) PEER REVIEWED Sharon L. Smith, DNP; Galia Siegel, PhD; Ashley Kennedy, PhD In recent years, the National Institutes of Health (NIH) has […]